| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |